PARP Inhibitor–Based Combinations to Improve Patient Outcomes in Prostate Cancer: An Evidence-Based Global Perspective

Download All
Learn about PARP inhibitor–based combination therapy in prostate cancer in this expert-authored online activity with downloadable slides, podcasts and a ClinicalThought.
Charles J. Ryan, MD

CME Expert-Authored, Interactive Online Activity

Review expert insights on PARP inhibitor combination approaches including combinations with AR-directed therapy and immune checkpoint inhibitors.

Charles J. Ryan, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: April 12, 2021 Expired: April 11, 2022
Provided by Clinical Care Options, LLC
Contact Info

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Pfizer Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue